391 results on '"Toba, Takayoshi"'
Search Results
52. Association Between Visit-to-Visit Variability in Low-Density Lipoprotein Cholesterol and Plaque Rupture That Leads to Acute Coronary Syndrome
53. Morphological Plaque Characteristics and Clinical Outcomes in Patients With Acute Coronary Syndrome and a Cancer History
54. Progression from normal vessel wall to atherosclerotic plaque: lessons from an optical coherence tomography study with follow-up of over 5 years
55. Varied Extent of Mitral Annular Disjunction Among Cases With Different Phenotypes of Mitral Valve Prolapse
56. Revival of Mitral and Tricuspid Annular Disjunctions
57. Adding Alirocumab to Rosuvastatin Helps Reduce the Vulnerability of Thin-Cap Fibroatheroma: An ALTAIR Trial Report
58. Normative Aortic Valvar Measurements in Adults Using Cardiac Computed Tomography ― A Potential Guide to Further Sophisticate Aortic Valve-Sparing Surgery ―
59. Potential relationship between high wall shear stress and plaque rupture causing acute coronary syndrome
60. Successful percutaneous balloon aortic valvuloplasty for worsening paravalvular leakage detected one week after the balloon expandable transcatheter aortic valve replacement
61. Impact of the Antithrombotic Effects of Prasugrel on Mid-Term Vascular Healing in Acute Coronary Syndrome vs. Stable Coronary Artery Disease
62. A rare case of concomitant aortic regurgitation and coronary ostial stenosis due to cardiovascular syphilis
63. A rare manifestation of primary cardiac intimal sarcoma: mimicking non-bacterial thrombotic endocarditis with severe mitral regurgitation
64. Absence of Myocardial Support at the Base of the Left Coronary Aortic Sinus in a Patient With Ehlers-Danlos Syndrome
65. Wall Shear Stress and Plaque Vulnerability
66. Efficacy of myocardial washout of 99mTc-MIBI/Tetrofosmin for the evaluation of inflammation in patients with cardiac sarcoidosis: comparison with 18F-fluorodeoxyglucose positron emission tomography findings.
67. Impact of daily glucose fluctuations on cardiovascular outcomes after percutaneous coronary intervention for patients with stable coronary artery disease undergoing lipid‐lowering therapy
68. Feasibility of morphological assessment of coronary artery calcification with electrocardiography-gated non-contrast computed tomography: a comparative study with optical coherence tomography
69. Concomitant Use of Rosuvastatin and Eicosapentaenoic Acid Significantly Prevents Native Coronary Atherosclerotic Progression in Patients With In-Stent Neoatherosclerosis
70. Three‐dimensional volumetric measurement of the aortic root compared to standard two‐dimensional measurements using cardiac computed tomography
71. CLINICAL CHARACTERISTICS AND MORPHOLOGICAL CULPRIT PLAQUE FEATURES IN PATIENTS WITH ACUTE CORONARY SYNDROME
72. VISIT-TO-VISIT VARIABILITY OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL MAY ASSOCIATE WITH PLAQUE RUPTURE LEADING TO ACUTE CORONARY SYNDROME
73. Revisiting the prevalence and diversity of localized thinning of the left ventricular apex
74. Ascending aortic elongation and correlative change in overall configuration of the proximal aorta in elderly patients with severe aortic stenosis
75. Prognostic Impact of Myocardial Extracellular Volume Fraction Assessment Using Dual-Energy Computed Tomography in Patients Treated With Aortic Valve Replacement for Severe Aortic Stenosis.
76. Morphological Plaque Characteristics and Clinical Outcomes in Patients With Acute Coronary Syndrome and a Cancer History.
77. Effect of rosuvastatin and eicosapentaenoic acid on neoatherosclerosis: the LINK-IT Trial
78. Localized basal left ventricular dyssynchrony induced by manifest accessory pathway: Successful differentiation from cardiac involvement of sarcoidosis with administration of flecainide acetate
79. TCT-408 Impact of Dedicated Dual Antiplatelet Therapy With Low-Dose Prasugrel on Mid-Term Vascular Response After Everolimus-Eluting Stent Implantation
80. TCT-13 Alirocumab Improve Coronary Plaque Vulnerability: First Randomized Control Trial to Assess the Effect of Alirocumab for Plaque Vulnerability Using Optical Coherence Tomography
81. Impaired Cholesterol‐Uptake Capacity of HDL Might Promote Target‐Lesion Revascularization by Inducing Neoatherosclerosis After Stent Implantation
82. Peri-strut low-intensity area assessed by midterm follow-up optical coherence tomography may predict target lesion revascularisation after everolimus-eluting stent implantation
83. Efficacy of alirocumab for reducing plaque vulnerability: Study protocol for ALTAIR, a randomized controlled trial in Japanese patients with coronary artery disease receiving rosuvastatin
84. Effect of Alirocumab and Rosuvastatin or Rosuvastatin Alone on Lipid Core Plaque in Coronary Artery Disease Seen on Near-Infrared Spectroscopy Intravascular Ultrasound (ANTARES)
85. Lumen boundaries extracted from coronary computed tomography angiography on computed fractional flow reserve (FFRCT): validation with optical coherence tomography
86. Impact of daily glucose fluctuations on cardiovascular outcomes after percutaneous coronary intervention for patients with stable coronary artery disease undergoing lipid‐lowering therapy.
87. Prevalence and extent of mitral annular disjunction in structurally normal hearts: comprehensive 3D analysis using cardiac computed tomography.
88. Three‐dimensional volumetric measurement of the aortic root compared to standard two‐dimensional measurements using cardiac computed tomography.
89. Critical exacerbation of idiopathic pulmonary fibrosis after transcatheter aortic valve implantation: Need for multidisciplinary care beyond “heart team”
90. Comparison of the 9-month intra-stent conditions and 2-year clinical outcomes after Resolute zotarolimus-eluting stent implantation between 3-month and standard dual antiplatelet therapy
91. Data on impact of monocytes and glucose fluctuation on plaque vulnerability in patients with coronary artery disease
92. Relationship between the membranous septum and the virtual basal ring of the aortic root in candidates for transcatheter implantation of the aortic valve
93. IMPAIRED HDL CHOLESTEROL UPTAKE CAPACITY WHICH MEASURE HDL FUNCTIONALITY MIGHT PROMOTE NEOATHEROSCLEROSIS FORMATION AFTER STENT IMPLANTATION
94. EFFECT OF ROSUVASTATIN AND EICOSAPENTAENOIC ACID ON NEOATHEROSCLEROSIS: THE LINK-IT TRIAL
95. Impact of CD14 ++ CD16 + monocytes on coronary plaque vulnerability assessed by optical coherence tomography in coronary artery disease patients
96. The first case of “locked-in leaflet” after transcatheter aortic valve replacement in a patient with bicuspid aortic stenosis
97. TCT-530 The combination of rosuvastatin (10mg) and eicosapentaenoic acid (1800mg) improved native coronary plaques > 5.7 years after stent implantation
98. TCT-452 High Wall Shear Stress was Strongly Associated with Plaque Vulnerability in Computational Fluid Dynamics with Combined Optical Coherence Tomography and Heartflow FFRCT Simulation
99. TCT-815 The clinical impact of daily glucose fluctuation on cardiovascular events in patients with stable angina pectoris pretreated with lipid-lowering therapy
100. Spontaneous coronary artery intramural hematoma in a patient with vascular Ehlers-Danlos syndrome: Serial findings in coronary computed tomographic angiography
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.